Vildagliptin + Metformin HCL
For the treatment of patients with Type 2
diabetes mellitus (T2DM):
As an adjunct
to diet and exercise to improve glycemic control in patients
whose diabetes is not adequately controlled on metformin HCl
alone or who are already treated with the combination of vildagliptin
and metformin HCl, as separate tablets.
with a sulfonylurea (i.e. triple combination therapy) as an
adjunct to diet and exercise in adult patients inadequately
controlled with metformin and a sulfonylurea.
In triple combination
therapy with insulin as an adjunct to diet and exercise to
improve glycemic control in adult patients when insulin at
a stable dose and metformin alone do not provide adequate
Wilda-M is used to treat type 2 diabetes mellitus in people who are already taking vildagliptin and metformin tablets separately, or whose diabetes cannot be controlled by metformin alone.
Tablets 50 mg/500 mg, 50 mg/850 mg, 50 mg/1000 mg